Evidence map›Paper›PMID 30643257›Full record

ArticleNature genetics2019

Fast and accurate genomic analyses using genome graphs.

Goran Rakocevic, Vladimir Semenyuk, Wan-Ping Lee, James Spencer, John Browning, Ivan J Johnson, Vladan Arsenijevic, Jelena Nadj, Kaushik Ghose, Maria C Suciu and 15 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 123 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
123citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

123 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Approaches to Studying Viral Pangenome Variation Graphs.Genomics, proteomics & bioinformatics · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

63 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Goran RakocevicSeven Bridges Genomics, Inc, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-3411-0764
Vladimir SemenyukSeven Bridges Genomics, Inc, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-7461-6153
Wan-Ping LeeSeven Bridges Genomics, Inc, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-5305-1181
James SpencerSeven Bridges Genomics, Inc, Cambridge, MA, USA.
John BrowningSeven Bridges Genomics, Inc, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-2997-8734
Ivan J JohnsonSeven Bridges Genomics, Inc, Cambridge, MA, USA.
Vladan ArsenijevicSeven Bridges Genomics, Inc, Cambridge, MA, USA.
Jelena NadjSeven Bridges Genomics, Inc, Cambridge, MA, USA.
Kaushik GhoseSeven Bridges Genomics, Inc, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-2933-1260
Maria C SuciuSeven Bridges Genomics, Inc, Cambridge, MA, USA.
Sun-Gou JiSeven Bridges Genomics, Inc, Cambridge, MA, USA.
Gülfem DemirSeven Bridges Genomics, Inc, Cambridge, MA, USA.
Lizao LiSeven Bridges Genomics, Inc, Cambridge, MA, USA.
Berke Ç ToptaşSeven Bridges Genomics, Inc, Cambridge, MA, USA.
Alexey DolgoborodovSeven Bridges Genomics, Inc, Cambridge, MA, USA.
Björn PollexSeven Bridges Genomics, Inc, Cambridge, MA, USA.
Iosif SpulberSeven Bridges Genomics, Inc, Cambridge, MA, USA.
Irina GlotovaSeven Bridges Genomics, Inc, Cambridge, MA, USA.
Péter KómárSeven Bridges Genomics, Inc, Cambridge, MA, USA.
Andrew L StachyraSeven Bridges Genomics, Inc, Cambridge, MA, USA.
Yilong LiSeven Bridges Genomics, Inc, Cambridge, MA, USA.
Milos PopovicSeven Bridges Genomics, Inc, Cambridge, MA, USA.
Morten KällbergSeven Bridges Genomics, Inc, Cambridge, MA, USA.
Amit JainSeven Bridges Genomics, Inc, Cambridge, MA, USA.
Deniz KuralSeven Bridges Genomics, Inc, Cambridge, MA, USA. deniz.kural@sbgenomics.com.ORCID http://orcid.org/0000-0002-8085-0771

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human reference genome serves as the foundation for genomics by providing a scaffold for alignment of sequencing reads, but currently only reflects a single consensus haplotype, thus impairing analysis accuracy. Here we present a graph reference genome implementation that enables read alignment across 2,800 diploid genomes encompassing 12.6 million SNPs and 4.0 million insertions and deletions (indels). The pipeline processes one whole-genome sequencing sample in 6.5 h using a system with 36 CPU cores. We show that using a graph genome reference improves read mapping sensitivity and produces a 0.5% increase in variant calling recall, with unaffected specificity. Structural variations incorporated into a graph genome can be genotyped accurately under a unified framework. Finally, we show that iterative augmentation of graph genomes yields incremental gains in variant calling accuracy. Our implementation is an important advance toward fulfilling the promise of graph genomes to radically enhance the scalability and accuracy of genomic analyses.

Indexed as

Genome, HumanGenomicsHumansPolymorphism, Single NucleotideSequence AlignmentSequence Analysis, DNASequence DeletionWhole Genome Sequencing

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.